Can vitamin C of Baobab pulp Tablet be a nutritional adjuvant to COVID 19 treatment?
Paper Details
Can vitamin C of Baobab pulp Tablet be a nutritional adjuvant to COVID 19 treatment?
Abstract
The relation between immunity and nutrition is high for well-being and against infections. In order to combat the coronavirus 2019 (COVID-19) viral pandemic, increased attention must also be paid to this relationship. However, the nutritional status of patients with COVID-19 is affected. The immunopathological changes in COVID-19 patients have affected their nutritional status and induced chronic damage in their organism. In this review, we highlight the nutritional treatment of COVID 19 with vitamin C therapy based on Baobab pulp tablets. Research has shown that high doses of 6 to 8g/day of vitamin C have been used for the treatment of several viral respiratory diseases such as COVID 19. We suggest that this pharmacological dose of vitamin C per day to enhance immunity and improve the nutritional status of COVID 19 patients. According to the nutritional profile of Baobab pulp Tablet, one hundred (100)g of this Tablet contains 428mg of vitamin C. Therefore, more than 14 Tablet of Baobab pulp can be used for moderate treatment of COVID 19. Thus, in this study, it is suggested that vitamin C therapy based on Baobab pulp tablet be used as an adjuvant to nutritional treatment of COVID 19. Clinical studies are required to confirm this hypothesis.
Balz Frei, Ines Birlouez-Aragon, Jens Lykkesfeldt. 2012. Authors’ Perspective: What is the Optimum Intake of Vitamin C in Humans? Critical Reviews in Food Science and Nutrition 52(9), 815.
Carr AC, Bozonet SM, Vissers MCM. 2013. A Randomised Cross-Over Pharmacokinetic Bioavailability Study of Synthetic versus Kiwifruit-Derived Vitamin C. Nutrients 5(11), 4451-4461.
Carr AC, Rosengrave PC, Bayer S, Chambers S, Mehrtens J, Shaw GM. 2017. Hypovitaminosis C and vitamin C deficiency in critically ill patients despite recommended enteral and parentera intakes. Critical Care 21:300. https://pubmed.ncbi.nlm.nih.
Carr AC, Spencer E, Dixon L, Chambers ST. 2020. Patients with community acquired pneumonia exhibit depleted vitamin C status and elevated oxidative stress. Nutrients 12-1318. https://www mdpi.com /20726643/12/5/1318.
Cathcart RF. 2011. The third face of vitamin C. Journal of Orthomolecular Medicine 7, 197-200.
Cheng R. 2020. Successful high-dose vitamin C treatment of patients with serious and critical COVID-19 infection. Orthomolecular 31, 03. http:// orthomolecular.org/resources/omns/v16n18.shtml.
Du Li-ping, Mei Dan, LI Da-kui, Chen Qi, Wang Zi-hou. 2020. Le traitement à fortes doses de Vitamine C dans les infections virales respiratoires graves. Orthomolecular Medicine News Service 10, 203-212.
Hemila H, Chalker E. 2013. Vitamin C for preventing and treating the common cold. Cochrane Database System Review, 1: CD000980. https://pubmed.ncbi.nlm.nih.gov/23440782.
Hemila H, Chalker E. 2019. Vitamin C can shorten the length of stay in the ICU: a meta-analysis. Nutrients. 11 (708). https://www.mdpi.com/2072-6643/11/4/708.
Huang C. 2020. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395, 497-506.
Imran MK. 2014. Efficacy of Vitamin C in Reducing Duration of Severe Pneumonia in Children. Journal of Rawalpindi Medical College (JRMC) 18(1), 55-57.
Jae Hyoung Im, Young SooJe, JihyeonBaek, Moon-HyunChung, Hea Yoon Kwon, Jin-SooLee. 2020. Nutritional status of patients with coronavirus disease 2019 (COVID-19). International Journal of Infectious Diseases (Elsevier) 10, 1016 https://doi.org/10.1016/j.ijid.2020.08.018.
Khan IM. 2014. Efficacy of vitamin C in reducing duration of severe pneumonia in children. J Rawalpindi Med Col (JRMC) 18(1), 55-57. https://www.journalrmc.com/volumes/1405749894.
Player G, Saul AW, Downing D, Schuitemaker G. 2020. Published Research and Articles on Vitamin C as a Consideration for Pneumonia, Lung Infections, and the Novel Coronavirus (SARS-CoV-2/COVID-19). Orthomolecular Medicine News Service.
Saul AW. 2020. Nutritional treatment of coronavirus. Orthomolecular Medicine News Service.
Stipp MM. 2020. SARS-Cov2: Micronutrient optimization in supporting host Immuno Competence. International Journal of clinical case reports a Reviews 2(2), 1-11.
Van Straten M, Josling P. 2002. Preventing the common cold with a vitamin C supplement: A double-blind, placebo-controlled survey. Advanced Therapy 19, 151.
Vodouhè Sènan, Kouton Sandrine E, Hounkpatin Waliou Amoussa, Soumanou Mohamed M. 2020. Bioavailability of Micronutrient in Functional Tablet Developed from Blend of Baobab pulp, Moringa Leaf Powder and Malted maize Flour for Iron Deficient Pregnant. International Journal of Applied Biology and Pharmaceutical Technology 11(3), 200-214.
World Health Organization. 2020. Infection prevention and control during health care when COVID-19 is suspected. https://www.who.int/ publications -detail/infection-prevention-and-control-during-health-care-when-novel-coronavirus-(ncov)infection-is-suspected-20200125.
Yejin K, Hyemin K, Seyeon B. 2013. Vitamin C is an essential factor on the anti-viral immune responses through the production of Interferon- α/β at the initial stage of Influenza A virus (H3N2) infection. Immune Network 13(2), 70-74. https://immunenetwork.org/DOIa
Sandrine Kouton, Waliou Amoussa Hounkpatin, Noel Tovidé, Mohamed Soumanou (2021), Can vitamin C of Baobab pulp Tablet be a nutritional adjuvant to COVID 19 treatment?; IJBB, V13, N3, September, P1-7
https://innspub.net/can-vitamin-c-of-baobab-pulp-tablet-be-a-nutritional-adjuvant-to-covid-19-treatment/
Copyright © 2021
By Authors and International
Network for Natural Sciences
(INNSPUB) https://innspub.net
This article is published under the terms of the
Creative Commons Attribution License 4.0